vaccines

Senate to Begin Deliberations on Latest COVID-19 Relief Bill
Risk & Compliance

Senate to Begin Deliberations on Latest COVID-19 Relief Bill

The $1.9 trillion relief bill was passed by the House over the weekend.
By Lauren Muskett | March 1, 2021
Read More
Retail Sales Fall 1.1% in Largest Pandemic Drop
The Economy

Retail Sales Fall 1.1% in Largest Pandemic Drop

“The economy will bounce back strongly in [Q2] as vaccine deployment reaches critical mass but until then it’s going to be a long, bleak winter."
By Matthew Heller | December 16, 2020
Read More
Early Analysis Shows Pfizer COVID-19 Vaccine 90% Effective
Risk & Compliance

Early Analysis Shows Pfizer COVID-19 Vaccine 90% Effective

The company said 50 million doses of its two-shot vaccine could be available globally by the end of 2020.
By Lauren Muskett | November 9, 2020
Read More
COVID-19 Vaccines Could Generate Over $10B Annual Revenue
Risk & Compliance

COVID-19 Vaccines Could Generate Over $10B Annual Revenue

Analysts estimate that people will need the vaccine every year, like a flu shot, at a projected cost of $20 per dose.
By Lauren Muskett | November 5, 2020
Read More
Lilly Buys Vetmedica Pet Vaccines for $885M
Strategy

Lilly Buys Vetmedica Pet Vaccines for $885M

The deal will diversify Lilly's Elanco animal medicine business, adding vaccines for rabies and other feline and canine illnesses.
By Matthew Heller | October 5, 2016
Read More